Literature DB >> 33743611

Metabolic parameters in cord blood of neonate of mothers with obese and non-obese PCOS and controls: retrospective cohort study.

Sanaz Alizadeh1, Shahideh Jahanian Sadatmahalleh1, Fatemeh Razavinia1, Mahnaz Bahri Khomami2, Malihe Nasiri3, Ashraf Moini4,5,6, Saeideh Ziaei7.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is characterized by reproductive disorder and increased risk of metabolic syndrome. This study aimed to assess the metabolic parameters in the cord blood of neonate of mothers with obese PCOS and comparison with non-obese PCOS and controls.
METHODS: This retrospective cohort study was conducted in Arash and Kamali Hospital in 2017-2018. The biochemical test was conducted on 78 neonates from obese PCOS mothers, 78 neonates from non-obese PCOS mothers, and 78 neonates from healthy mothers. Finally, cord blood lipid profile and insulin and blood sugar were determined by specific kits. Correlations between variables were compared with chi-square, Mann-Whitney's U, Kruskal-Wallis H tests and regression model by SPSS 23 and P < 0.05 was considered significant.
RESULTS: Triglycerides (TG) and high-density lipoprotein cholesterol (HDL) were higher in cord blood of newborn of obese PCOS women than non-obese PCOS and controls (P = 0.02, P < 0.001, respectively). Also, the mean insulin was higher in cord blood of neonate of non-obese PCOS women than in obese PCOS and controls (12.26 ± 12.79 vs. 11.11 ± 16.51 vs. 6.21 ± 10.66, P = 0.01). But in the study, there was no significant difference between the mean of umbilical cord low-density lipoprotein cholesterol (LDL), total cholesterol and blood sugar in three groups. The logistic regression model showed that metabolic parameters were related to PCOS.
CONCLUSIONS: In the present study, there was a significant difference between the mean of umbilical cord HDL, cholesterol, and the insulin level in the three groups. But, there was no significant association between the mean of blood sugar, LDL, and TG in the groups. The metabolic disorder in PCOS might affect cord blood lipid and insulin and adulthood health.

Entities:  

Keywords:  Metabolic parameters; Neonate; Polycystic ovary syndrome; Pregnancy

Mesh:

Substances:

Year:  2021        PMID: 33743611      PMCID: PMC7981878          DOI: 10.1186/s12884-021-03697-6

Source DB:  PubMed          Journal:  BMC Pregnancy Childbirth        ISSN: 1471-2393            Impact factor:   3.007


  24 in total

Review 1.  Fetal programming and metabolic syndrome.

Authors:  Paolo Rinaudo; Erica Wang
Journal:  Annu Rev Physiol       Date:  2011-09-09       Impact factor: 19.318

Review 2.  Excess Body Weight, Insulin Resistance and Isolated Systolic Hypertension: Potential Pathophysiological Links.

Authors:  Lanfranco D'Elia; Pasquale Strazzullo
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-11-02

3.  Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels.

Authors:  Helen Anderson; Naomi Fogel; Stefan K Grebe; Ravinder J Singh; Robert L Taylor; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2010-03-12       Impact factor: 5.958

4.  Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects.

Authors:  J-P Baillargeon; A C Carpentier
Journal:  Diabetologia       Date:  2007-09-27       Impact factor: 10.122

5.  Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006.

Authors:  William D Johnson; Jolanda J M Kroon; Frank L Greenway; Claude Bouchard; Donna Ryan; Peter T Katzmarzyk
Journal:  Arch Pediatr Adolesc Med       Date:  2009-04

6.  Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone.

Authors:  Richard S Legro; Ricardo Azziz; David Ehrmann; Anita Gmerek Fereshetian; Mary O'Keefe; Mahmoud N Ghazzi
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

Review 7.  Obesity and the polycystic ovary syndrome.

Authors:  A Gambineri; C Pelusi; V Vicennati; U Pagotto; R Pasquali
Journal:  Int J Obes Relat Metab Disord       Date:  2002-07

8.  Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria.

Authors:  Andy Huang; Kathleen Brennan; Ricardo Azziz
Journal:  Fertil Steril       Date:  2009-02-26       Impact factor: 7.329

9.  Physical inactivity rapidly induces insulin resistance and microvascular dysfunction in healthy volunteers.

Authors:  Naomi M Hamburg; Craig J McMackin; Alex L Huang; Sherene M Shenouda; Michael E Widlansky; Eberhard Schulz; Noyan Gokce; Neil B Ruderman; John F Keaney; Joseph A Vita
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-10-11       Impact factor: 8.311

10.  Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls.

Authors:  Ferdous Mehrabian; Roya Kelishadi
Journal:  J Res Med Sci       Date:  2012-03       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.